...Manchester, U.K. Business: Diagnostics/Imaging Appointed: Benjamin Matzilevich as CEO, formerly VP of business development at CN Biosciences Inc. WIR...

...analysis company Tepnel Life Sciences (LSE:TED). He was formerly vice president of business development at CN Biosciences...

...sciences research. Prolinx retains all rights to commercial applications of Versalinx. Prolinx Inc., Bothell, Wash. CN Biosciences Inc....

...technology Appointed: Val Buonaiuto, senior advisor to Hitachi Instruments Inc.; and Stelios Papadopoulos, CEO of CN Biosciences Inc. WIR...

...target in this indication. L-NMMA is a research reagent sold by Clinalfa, a division of CN Biosciences Inc....

...affiliate acquired CNBI for $146 million in cash. CNBI’s San Diego facility will be retained. CN Biosciences Inc....

...Chromagen. CNBI made an undisclosed equity investment in Chromagen. Chromagen Inc. , San Diego, Calif. CN Biosciences Inc....

...years SSB's signal transduction reagents. SSB retains the right to directly market the products worldwide. CN Biosciences Inc....

...and purification systems for research. CNBI expects Novagen's 1997 sales to be about $4 million. CN Biosciences Inc....

...OVERHANG Follow-ons Shares Price at filing ArQule (ARQL) 1.6 million $19.50 CN Biosciences (CNBI) 90,000 $15.00 Guilford...